Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Sprague

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Kidney International|September 21, 2007
Mortality risk among hemodialysis patients receiving different vitamin D analogsS M Sprague
Seminars in Dialysis|June 2, 2000
The role of the bone biopsy in the diagnosis of renal osteodystrophyS M Sprague
Pediatric Nephrology (Berlin, Germany)|July 27, 2000
Mechanism of transplantation-associated bone lossS M Sprague
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosisT Miyata, S M Sprague
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 9, 2003
Dialysis-related amyloidosisG Dzido, S M Sprague
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2001
Beta(2)-microglobulin and bone cell metabolismE Balint, S M Sprague
Clinical Nephrology|October 1, 1994
Uremic encephalopathyS M Moe, S M Sprague
The American Journal of Physiology|March 1, 1990
Mechanism of aluminum-induced calcium efflux from cultured neonatal mouse calvariaeS M Sprague, D A Bushinsky
Kidney International|January 1, 1995
Is beta 2-microglobulin a mediator of bone disease?S M Sprague, M M Popovtzer
Clinical Nephrology|September 14, 2002
Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patientS M Sprague, L T Ho
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Kidney International|September 21, 2007
Mortality risk among hemodialysis patients receiving different vitamin D analogsS M Sprague
Seminars in Dialysis|June 2, 2000
The role of the bone biopsy in the diagnosis of renal osteodystrophyS M Sprague
Pediatric Nephrology (Berlin, Germany)|July 27, 2000
Mechanism of transplantation-associated bone lossS M Sprague
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosisT Miyata, S M Sprague
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 9, 2003
Dialysis-related amyloidosisG Dzido, S M Sprague
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2001
Beta(2)-microglobulin and bone cell metabolismE Balint, S M Sprague
Clinical Nephrology|October 1, 1994
Uremic encephalopathyS M Moe, S M Sprague
The American Journal of Physiology|March 1, 1990
Mechanism of aluminum-induced calcium efflux from cultured neonatal mouse calvariaeS M Sprague, D A Bushinsky
Kidney International|January 1, 1995
Is beta 2-microglobulin a mediator of bone disease?S M Sprague, M M Popovtzer
Clinical Nephrology|September 14, 2002
Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patientS M Sprague, L T Ho
Pageof 5